Go Pro
→ You’ve never seen anything like this before (From Porter & Company) (Ad)tc pixel Free CTEC Stock Alerts

ConvaTec Group (CTEC) Competitors

ConvaTec Group logo
GBX 215.80 -2.00 (-0.92%)
As of 09/11/2026 12:15 PM Eastern
Compare

CTEC vs. SN, AMS, NIOX, TSTL, and SPEC

Should you buy ConvaTec Group stock or one of its competitors? ConvaTec Group's main competitors and comparable companies include Smith & Nephew (SN), Advanced Medical Solutions Group (AMS), NIOX Group (NIOX), Tristel (TSTL), and INSPECS Group (SPEC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does ConvaTec Group compare to Smith & Nephew?

ConvaTec Group (LON:CTEC) and Smith & Nephew (LON:SN) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

ConvaTec Group pays an annual dividend of GBX 7.25 per share and has a dividend yield of 3.4%. Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.9%. ConvaTec Group pays out 116.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

68.4% of ConvaTec Group shares are owned by institutional investors. Comparatively, 62.2% of Smith & Nephew shares are owned by institutional investors. 1.0% of ConvaTec Group shares are owned by insiders. Comparatively, 0.2% of Smith & Nephew shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, ConvaTec Group had 1 more articles in the media than Smith & Nephew. MarketBeat recorded 2 mentions for ConvaTec Group and 1 mentions for Smith & Nephew. Smith & Nephew's average media sentiment score of 0.15 beat ConvaTec Group's score of -0.38 indicating that Smith & Nephew is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ConvaTec Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Smith & Nephew
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Smith & Nephew has higher revenue and earnings than ConvaTec Group. ConvaTec Group is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ConvaTec Group£2.49B1.68£188.35M£6.2034.81
Smith & Nephew£7.08B1.56£382.79M£27.7736.31

ConvaTec Group presently has a consensus target price of GBX 305.44, indicating a potential upside of 41.54%. Smith & Nephew has a consensus target price of GBX 1,310, indicating a potential upside of 29.90%. Given ConvaTec Group's stronger consensus rating and higher possible upside, equities analysts plainly believe ConvaTec Group is more favorable than Smith & Nephew.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ConvaTec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
Smith & Nephew
0 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33

ConvaTec Group has a beta of 0.765, meaning that its share price is 24% less volatile than the broader market. Comparatively, Smith & Nephew has a beta of 0.688, meaning that its share price is 31% less volatile than the broader market.

Smith & Nephew has a net margin of 10.08% compared to ConvaTec Group's net margin of 4.99%. Smith & Nephew's return on equity of 12.25% beat ConvaTec Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ConvaTec Group4.99% 8.40% 5.01%
Smith & Nephew 10.08%12.25%4.51%

Summary

ConvaTec Group beats Smith & Nephew on 10 of the 18 factors compared between the two stocks.

How does ConvaTec Group compare to Advanced Medical Solutions Group?

ConvaTec Group (LON:CTEC) and Advanced Medical Solutions Group (LON:AMS) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk.

ConvaTec Group has higher revenue and earnings than Advanced Medical Solutions Group. ConvaTec Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ConvaTec Group£2.49B1.68£188.35M£6.2034.81
Advanced Medical Solutions Group£228.94M2.67£11.22M£4.5262.06

ConvaTec Group has a net margin of 4.99% compared to Advanced Medical Solutions Group's net margin of 4.35%. ConvaTec Group's return on equity of 8.40% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ConvaTec Group4.99% 8.40% 5.01%
Advanced Medical Solutions Group 4.35%3.87%2.35%

ConvaTec Group pays an annual dividend of GBX 7.25 per share and has a dividend yield of 3.4%. Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.0%. ConvaTec Group pays out 116.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend.

68.4% of ConvaTec Group shares are owned by institutional investors. Comparatively, 21.5% of Advanced Medical Solutions Group shares are owned by institutional investors. 1.0% of ConvaTec Group shares are owned by company insiders. Comparatively, 4.0% of Advanced Medical Solutions Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, ConvaTec Group had 2 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 2 mentions for ConvaTec Group and 0 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 0.00 beat ConvaTec Group's score of -0.38 indicating that Advanced Medical Solutions Group is being referred to more favorably in the news media.

Company Overall Sentiment
ConvaTec Group Neutral
Advanced Medical Solutions Group Neutral

ConvaTec Group currently has a consensus price target of GBX 305.44, indicating a potential upside of 41.54%. Advanced Medical Solutions Group has a consensus price target of GBX 270.25, indicating a potential downside of 3.65%. Given ConvaTec Group's stronger consensus rating and higher probable upside, analysts plainly believe ConvaTec Group is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ConvaTec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

ConvaTec Group has a beta of 0.765, suggesting that its share price is 24% less volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.704, suggesting that its share price is 30% less volatile than the broader market.

Summary

ConvaTec Group beats Advanced Medical Solutions Group on 13 of the 18 factors compared between the two stocks.

How does ConvaTec Group compare to NIOX Group?

NIOX Group (LON:NIOX) and ConvaTec Group (LON:CTEC) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation.

NIOX Group pays an annual dividend of GBX 1.25 per share and has a dividend yield of 1.9%. ConvaTec Group pays an annual dividend of GBX 7.25 per share and has a dividend yield of 3.4%. NIOX Group pays out 76.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ConvaTec Group pays out 116.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

NIOX Group has higher earnings, but lower revenue than ConvaTec Group. ConvaTec Group is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NIOX Group£48.70M5.64£995.88M£1.6439.77
ConvaTec Group£2.49B1.68£188.35M£6.2034.81

7.6% of NIOX Group shares are owned by institutional investors. Comparatively, 68.4% of ConvaTec Group shares are owned by institutional investors. 5.1% of NIOX Group shares are owned by insiders. Comparatively, 1.0% of ConvaTec Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

NIOX Group has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market. Comparatively, ConvaTec Group has a beta of 0.765, meaning that its stock price is 24% less volatile than the broader market.

NIOX Group has a net margin of 14.37% compared to ConvaTec Group's net margin of 4.99%. NIOX Group's return on equity of 10.14% beat ConvaTec Group's return on equity.

Company Net Margins Return on Equity Return on Assets
NIOX Group14.37% 10.14% 3.95%
ConvaTec Group 4.99%8.40%5.01%

NIOX Group presently has a consensus price target of GBX 86, indicating a potential upside of 31.87%. ConvaTec Group has a consensus price target of GBX 305.44, indicating a potential upside of 41.54%. Given ConvaTec Group's higher possible upside, analysts plainly believe ConvaTec Group is more favorable than NIOX Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NIOX Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
ConvaTec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89

In the previous week, ConvaTec Group had 2 more articles in the media than NIOX Group. MarketBeat recorded 2 mentions for ConvaTec Group and 0 mentions for NIOX Group. NIOX Group's average media sentiment score of 0.00 beat ConvaTec Group's score of -0.38 indicating that NIOX Group is being referred to more favorably in the media.

Company Overall Sentiment
NIOX Group Neutral
ConvaTec Group Neutral

Summary

NIOX Group beats ConvaTec Group on 10 of the 18 factors compared between the two stocks.

How does ConvaTec Group compare to Tristel?

ConvaTec Group (LON:CTEC) and Tristel (LON:TSTL) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment.

ConvaTec Group has a beta of 0.765, indicating that its stock price is 24% less volatile than the broader market. Comparatively, Tristel has a beta of 0.344, indicating that its stock price is 66% less volatile than the broader market.

Tristel has a net margin of 15.88% compared to ConvaTec Group's net margin of 4.99%. Tristel's return on equity of 23.64% beat ConvaTec Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ConvaTec Group4.99% 8.40% 5.01%
Tristel 15.88%23.64%9.89%

In the previous week, ConvaTec Group had 2 more articles in the media than Tristel. MarketBeat recorded 2 mentions for ConvaTec Group and 0 mentions for Tristel. Tristel's average media sentiment score of 0.00 beat ConvaTec Group's score of -0.38 indicating that Tristel is being referred to more favorably in the news media.

Company Overall Sentiment
ConvaTec Group Neutral
Tristel Neutral

ConvaTec Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ConvaTec Group£2.49B1.68£188.35M£6.2034.81
Tristel£49.54M3.86£6.54M£16.2424.48

ConvaTec Group pays an annual dividend of GBX 7.25 per share and has a dividend yield of 3.4%. Tristel pays an annual dividend of GBX 14.20 per share and has a dividend yield of 3.6%. ConvaTec Group pays out 116.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Tristel pays out 87.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Tristel is clearly the better dividend stock, given its higher yield and lower payout ratio.

68.4% of ConvaTec Group shares are held by institutional investors. Comparatively, 22.4% of Tristel shares are held by institutional investors. 1.0% of ConvaTec Group shares are held by company insiders. Comparatively, 21.0% of Tristel shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

ConvaTec Group presently has a consensus target price of GBX 305.44, indicating a potential upside of 41.54%. Given ConvaTec Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe ConvaTec Group is more favorable than Tristel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ConvaTec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
Tristel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

ConvaTec Group and Tristel tied by winning 9 of the 18 factors compared between the two stocks.

How does ConvaTec Group compare to INSPECS Group?

INSPECS Group (LON:SPEC) and ConvaTec Group (LON:CTEC) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

ConvaTec Group has higher revenue and earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INSPECS Group£191.70M0.55-£4.11M-£9.40N/A
ConvaTec Group£2.49B1.68£188.35M£6.2034.81

ConvaTec Group has a net margin of 4.99% compared to INSPECS Group's net margin of -2.67%. ConvaTec Group's return on equity of 8.40% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
INSPECS Group-2.67% -6.07% 0.45%
ConvaTec Group 4.99%8.40%5.01%

In the previous week, INSPECS Group had 2 more articles in the media than ConvaTec Group. MarketBeat recorded 4 mentions for INSPECS Group and 2 mentions for ConvaTec Group. INSPECS Group's average media sentiment score of -0.34 beat ConvaTec Group's score of -0.38 indicating that INSPECS Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
INSPECS Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
ConvaTec Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

INSPECS Group has a beta of 1.603, meaning that its stock price is 60% more volatile than the broader market. Comparatively, ConvaTec Group has a beta of 0.765, meaning that its stock price is 24% less volatile than the broader market.

INSPECS Group presently has a consensus price target of GBX 60, indicating a potential downside of 37.50%. ConvaTec Group has a consensus price target of GBX 305.44, indicating a potential upside of 41.54%. Given ConvaTec Group's higher probable upside, analysts clearly believe ConvaTec Group is more favorable than INSPECS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
ConvaTec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89

0.2% of INSPECS Group shares are owned by institutional investors. Comparatively, 68.4% of ConvaTec Group shares are owned by institutional investors. 19.6% of INSPECS Group shares are owned by company insiders. Comparatively, 1.0% of ConvaTec Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

ConvaTec Group beats INSPECS Group on 11 of the 16 factors compared between the two stocks.

Get ConvaTec Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTEC vs. The Competition

Export
MetricConvaTec GroupHealthcare Equipment & Supplies IndustryHealthcare SectorLON Exchange
Market Cap£4.19B£5.42B£7.16B£2.87B
Dividend Yield2.45%1.79%2.56%6.23%
P/E Ratio34.8124.86274.10366.83
Price / Sales1.6882.29656.0083,599.70
Price / Cash17.0132.5377.0427.89
Price / Book2.705.9710.336.33
Net Income£188.35M£150.14M£3.50B£5.89B
7 Day Performance-4.17%-2.83%-3.35%-0.69%
1 Month Performance-7.86%-3.09%-0.43%0.18%
1 Year Performance-8.56%9.34%19.21%20.03%

ConvaTec Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTEC
ConvaTec Group
4.5229 of 5 stars		GBX 215.80
-0.9%		GBX 305.44
+41.5%		-8.2%£4.19B£2.49B34.8110,000
SN
Smith & Nephew
4.2644 of 5 stars		GBX 1,026
-3.6%		GBX 1,310
+27.7%		-27.4%£11.25B£7.08B36.9418,452
AMS
Advanced Medical Solutions Group
N/AGBX 280.50
-0.2%		GBX 270.25
-3.7%		+35.5%£610.38M£228.94M62.0610
NIOX
NIOX Group
N/AGBX 65
-2.7%		GBX 86
+32.3%		-7.4%£273.56M£48.70M39.6392
TSTL
Tristel
N/AGBX 408.43
-0.4%		N/A+12.9%£196.34M£49.54M25.15208

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:CTEC) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners
100% overnight gains?
Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...
The Oxford Club | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
My ‘one day’ retirement secret
TradeSmith's AI research team, backed by a $17 million investment and led by a former NSA codebreaker, built a...
TradeSmith | Sponsoredtc pixel
This 38 Dollar Fund Holds Every Major AI Stock and Pays Weekly
The biggest AI stocks like Nvidia, CrowdStrike, and Palantir now trade for hundreds of dollars a share. One fu...
Investors Alley | Sponsoredtc pixel
The retirement income that answers “yes” when everything else says no
Todd Phillips has spent 30 years studying safe-money income. He says most so-called income sources fail one te...
Eagle Publishing | Sponsoredtc pixel
17 Nobel Prize winners… one startling warning
On July 13, 17 Nobel laureates including Bernanke, Krugman, and Stiglitz signed an 88-word letter warning that...
Porter & Company | Sponsoredtc pixel
your job is on the list
The CEO of one of the largest AI labs on earth said it plainly: AI could wipe out half of all entry-level whit...
Behind the Markets | Sponsoredtc pixel
I called NVDA at $6 - Here's what’s next…
Matt McCall called NVDA at 6 dollars - it's since climbed more than 3,100 percent. He's identified 51 stocks t...
Monument Traders Alliance | Sponsoredtc pixel